Skip to main content
. 2021 Jul 19;40(9):e333–e339. doi: 10.1097/INF.0000000000003247

FIGURE 3.

FIGURE 3.

Overall per-subject incidence of general adverse events (AEs; %) during the 7-day (days 0–6) postvaccination period across the primary dose series (TVC).* *Detailed results are provided in Supplemental Digital Content 6; http://links.lww.com/INF/E463. AS03 is an adjuvant system containing DL-α-tocopherol and squalene in oil-in-water emulsion (AS03B containing 5.93 mg DL-α-tocopherol, AS03C containing 2.97 mg DL-α-tocopherol, and AS03D containing 1.48 mg DL-α-tocopherol).